Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.2400 (5.75%) ($4.7600 - $5.2400) on Tue. Jul. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.27% (three month average) | RSI | 70 | Latest Price | $5.2400(5.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.8% a day on average for past five trading days. | Weekly Trend | BCRX advances 8.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) GDX(7%) XLC(7%) XLU(7%) GDXJ(6%) REMX(6%) | Factors Impacting BCRX price | BCRX will decline at least -3.635% in a week (0% probabilities). EWP(-4%) DRIV(-4%) SMH(-3%) UUP(-2%) URA(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.635% (StdDev 7.27%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $5.32(-1.5%) | 10 Day Moving Average | $5.17(1.35%) | 20 Day Moving Average | $4.77(9.85%) | To recent high | -6.2% | To recent low | 4.5% | Market Cap | $924m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |